Home Cart Sign in  
Chemical Structure| 1227158-85-1 Chemical Structure| 1227158-85-1

Structure of BAY 87-2243
CAS No.: 1227158-85-1

Chemical Structure| 1227158-85-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BAY 87-2243 demonstrates high potency and selectivity as a hypoxia-inducible factor-1 (HIF-1) inhibitor.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BAY 87-2243

CAS No. :1227158-85-1
Formula : C26H26F3N7O2
M.W : 525.53
SMILES Code : FC(F)(F)OC1=CC=C(C2=NOC(C3=NN(CC4=CC(N5CCN(C6CC6)CC5)=NC=C4)C(C)=C3)=N2)C=C1
MDL No. :MFCD28143915
InChI Key :CDJNNOJINJAXPV-UHFFFAOYSA-N
Pubchem ID :67377767

Safety of BAY 87-2243

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of BAY 87-2243

epigenetics

Isoform Comparison

Biological Activity

Target
  • HIF

In Vitro:

Cell Line
Concentration Treated Time Description References
SK-MEL-28 10 nM 72 hours BAY 87-2243 significantly reduced cell viability and induced cell death PMC4615872
A-375 10 nM 8 hours BAY 87-2243 induced partial depolarization of the mitochondrial membrane potential PMC4615872
G-361 10 nM 16 hours BAY 87-2243 increased intracellular reactive oxygen species (ROS) levels PMC4615872
G361 cells 10 nM 48 hours To investigate the mechanism of BAY-induced cell death, BAY treatment significantly reduced the viability of G361 cells. PMC5386536
SK-MEL-28 cells 10 nM 72 hours To investigate the mechanism of BAY-induced cell death, BAY treatment significantly reduced the viability of SK-MEL-28 cells. PMC5386536
HLE-B3 cells 100 nM 12 days BAY 87-2243 significantly inhibited the proliferation of HLE-B3 cells and the expression levels of VEGF, and the combination with vitamin C further inhibited these effects. PMC7248485
Embryonic Submandibular Gland (SMG) 50 and 100 µM 4 hours Inhibited the expression of HIF-1α, thereby suppressing salivary gland development PMC8804608
A549 and HCC827 cells 5 µM 48 hours BAY 87-2243 increased IDH3α expression in BJ1 fibroblasts in co-culture with A549 and HCC827, but did not downregulate MCT4 expression, and induced apoptosis and death in carcinoma cells. PMC9259095
SKOV3 cells 1 µM 72 hours BAY 87-2243 completely inhibited mitochondrial respiration in SKOV3 cells, significantly reduced cell proliferation, and did not trigger massive apoptosis. PMC9653258
HCT116 cells 1 µM 72 hours BAY 87-2243 completely inhibited mitochondrial respiration in HCT116 cells, significantly reduced cell proliferation, and did not trigger massive apoptosis. PMC9653258
B16-F10 cells 20 µM 72 hours BAY 87-2243 completely inhibited mitochondrial respiration in B16-F10 cells, significantly reduced cell proliferation, and did not trigger massive apoptosis. PMC9653258

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice BRAF mutant melanoma xenograft model Oral 75 mg/kg Twice weekly, until tumors reached 2000 mm³ or 5 weeks BAY 87-2243 significantly reduced tumor growth without affecting body weight of the mice PMC4615872

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.90mL

0.38mL

0.19mL

9.51mL

1.90mL

0.95mL

19.03mL

3.81mL

1.90mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories